Don't have an account?
Research and Development is central to what we do, underpinning our commitment to shaping the future of radiopharma and contrast media imaging diagnostics. We are innovating to bring to market imaging agents, and the technologies to support them, to help enhance diagnosis and monitoring across neurology, oncology and cardiology care pathways, tackling unmet needs - to help improve outcomes for customers and their patients.